St John D J, McDermott F T, Hopper J L, Debney E A, Johnson W R, Hughes E S
Department of Gastroenterology, Royal Melbourne Hospital, VIC, Australia.
Ann Intern Med. 1993 May 15;118(10):785-90. doi: 10.7326/0003-4819-118-10-199305150-00005.
To quantify any risk for colorectal cancer in first-degree relatives of patients with common colorectal cancer and to define possible markers for increased risk.
Case-control family study.
Relatives of colorectal cancer patients and of matched control patients from a one-surgeon practice.
Family medical histories were obtained for 7493 first-degree relatives and 1015 spouses of 523 case-control pairs. Reported diagnoses of colorectal cancer in relatives were verified in 79% of instances.
By case-control analysis, the odds ratio was 1.8 (95% CI, 1.2 to 2.7) for one and 5.7 (CI, 1.7 to 19.3) for two affected relatives. By matched analysis of risk in relatives, the increased risk to parents and siblings was 2.1 times greater for case patients than for control patients (CI, 1.4 to 3.1); 3.7 times greater (CI, 1.5 to 9.1) with case patients diagnosed before 45; and 1.8 times greater (CI, 1.2 to 2.9) with case patients diagnosed at 45 years or older; and was independent of gender, type of relative, site of cancer, and type of cancer (single or multiple). The cumulative incidence among first-degree relatives was greater for case patients than for control patients (P < 0.001), and in case patients, greater for those diagnosed before 55 years of age (P < 0.001). The cumulative incidence (+/- S.E.) to age 80 was 11.1% +/- 1.3%, 7.3% +/- 0.8%, and 4.4% +/- 1.0% among relatives of case patients diagnosed before age 45 years, between 45 and 54 years, and at 55 years or older, respectively, and was 2.4% +/- 0.6% in relatives of control patients.
First-degree relatives of patients with common colorectal cancer have an increased risk for colorectal cancer. This risk is greater if diagnosis was at an early and is greater when other first-degree relatives are affected. This increased risk should be considered when formulating screening strategies.
量化普通结直肠癌患者一级亲属患结直肠癌的风险,并确定可能的风险增加标志物。
病例对照家系研究。
来自一名外科医生诊所的结直肠癌患者亲属及匹配的对照患者亲属。
获取了523例病例对照对中7493名一级亲属和1015名配偶的家族病史。亲属报告的结直肠癌诊断在79%的情况下得到了核实。
通过病例对照分析,有一名患病亲属时比值比为1.8(95%可信区间,1.2至2.7),有两名患病亲属时为5.7(可信区间,1.7至19.3)。通过对亲属风险的匹配分析,病例患者的父母和兄弟姐妹的风险增加是对照患者的2.1倍(可信区间,1.4至3.1);病例患者在45岁之前确诊时风险增加3.7倍(可信区间,1.5至9.1);病例患者在45岁及以上确诊时风险增加1.8倍(可信区间,1.2至2.9);且与性别、亲属类型、癌症部位和癌症类型(单发或多发)无关。病例患者一级亲属的累积发病率高于对照患者(P < 0.001),在病例患者中,55岁之前确诊的患者累积发病率更高(P < 0.001)。在45岁之前、45至54岁以及55岁及以上确诊的病例患者亲属中,至80岁时的累积发病率(±标准误)分别为11.1% ± 1.3%、7.3% ± 0.8%和4.4% ± 1.0%,对照患者亲属的累积发病率为2.4% ± 0.6%。
普通结直肠癌患者的一级亲属患结直肠癌的风险增加。如果诊断较早,这种风险会更高,当其他一级亲属患病时风险也会更高。在制定筛查策略时应考虑到这种增加的风险。